Biosynthetic Technologies Overview

  • Founded

  • 2004

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 15

Employees
  • Latest Deal Type

  • Series A1

  • Latest Deal Amount

  • $7.5M

  • Investors

  • 3

Biosynthetic Technologies General Information

Description

Developer of biobased synthetic compounds designed to manufacture bio-synthetic lubricant products. The company uses a patented technology that converts fatty acids found in plant and animal oils into synthetic lubricant base oils, enabling businesses to use them for making lubricant, chemical, and cosmetics products, often outperforming their petroleum counterparts in similar applications.

Contact Information

Website
www.biosynthetic.com
Formerly Known As
LubriGreen Biosynthetics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Specialty Chemicals
Other Industries
Industrial Chemicals
Other Commercial Products
Primary Office
  • 6320 Intech Boulevard
  • Indianapolis, IN 46278
  • United States
+1 (317) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosynthetic Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A1) 02-Feb-2022 $7.5M 0000 Completed Generating Revenue
9. Later Stage VC (Series A) 23-Mar-2019 00.00 00.00 Completed Generating Revenue
8. Secondary Transaction - Private 05-Jun-2019 Completed Generating Revenue
7. Merger/Acquisition 23-Mar-2018 000 00000 000 Completed Generating Revenue
6. Later Stage VC 07-Feb-2017 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series D) 01-Feb-2016 Cancelled Generating Revenue
4. Debt - General 01-Feb-2016 00000 00000 Completed Generating Revenue
3. Later Stage VC 02-Oct-2014 0000 000.00 Completed Generating Revenue
2. Later Stage VC 07-Aug-2013 $23.7M $30.7M Completed Generating Revenue
1. Later Stage VC 11-May-2012 $7M $7M Completed Generating Revenue
To view Biosynthetic Technologies’s complete valuation and funding history, request access »

Biosynthetic Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biobased synthetic compounds designed to manufacture bio-synthetic lubricant products. The company uses a p
Specialty Chemicals
Indianapolis, IN
15 As of 2022
0000
00000000000 0000

000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
000000000 000000000
Pearl River, NY
00 As of 0000
000.00
0000000000 0 000.00

000000

is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
00000 0000000000 00000000
Seattle, WA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosynthetic Technologies Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Anellotech Venture Capital-Backed Pearl River, NY 00 000.00 0000000000 0 000.00
000000 Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
000 00000000000 Private Equity-Backed La Porte, TX 00 000000000000
000000 0000000000 Venture Capital-Backed Ann Arbor, MI 00 00.00 0000000000 0 00.00
00000000000000 Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Biosynthetic Technologies Patents

  • 210

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 18

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Biosynthetic Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170152209-A1 Ultra high-viscosity estolide base oils and method of making the same Abandoned 30-Nov-2015 0000000000 0
EP-3383983-A1 Ultra high-viscosity estolide base oils and method of making the same Withdrawn 30-Nov-2015 0000000000
AU-2016364959-A1 Ultra high-viscosity estolide base oils and method of making the same Abandoned 30-Nov-2015 0000000000
US-20160280631-A1 Ester compounds including triesters having terminal vicinal acyl groups Abandoned 25-Mar-2015 0000000000
US-20160244397-A1 Processes for preparing estolide base oils and biobased compounds that include ethyleneolysis Abandoned 20-Feb-2015 C07C67/465 0
To view Biosynthetic Technologies’s complete patent history, request access »

Biosynthetic Technologies Executive Team (12)

Name Title Board Seat Contact Info
Mark Miller Chief Executive Officer and Board Member
Jakob Bredsguard President
Jeremy Forest JD Chief IP Counsel
Matthew Kriech Ph.D Chief Operating Officer
You’re viewing 4 of 12 executive team members. Get the full list »

Biosynthetic Technologies Board Members (11)

Name Representing Role Since
John Glushik HG Ventures Board Member 000 0000
Joseph Maslowski Self Board Member 000 0000
Mark Miller Biosynthetic Technologies Chief Executive Officer and Board Member 000 0000
You’re viewing 3 of 11 board members. Get the full list »

Biosynthetic Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosynthetic Technologies Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BP Ventures Corporate Venture Capital Minority 000 0000 000000 0
Calumet Specialty Products Partners Corporation Majority 000 0000 000000 0
Evonik Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
Sime Darby Corporation Minority 000 0000 000000 0
To view Biosynthetic Technologies’s complete investors history, request access »

Biosynthetic Technologies Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 10-Jan-2022 0000000000 Distributors/Wholesale 0000 0000
To view Biosynthetic Technologies’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Biosynthetic Technologies Subsidiaries (1)

Company Name Industry Location Founded
0000000 Distributors/Wholesale Macedonia, OH 0000
To view Biosynthetic Technologies’s complete subsidiaries history, request access »